The downregulation of PD-1 was also observed in Tregs isolated from tumor tissues following AICAR treatment (Fig. S9C), and combination therapy with AICAR with anti-CTLA4 antibody significantly reduced the tumor growth due to increased antitumor T cell activity in comparison with AICAR monotherapy (Fig. S9A-C). This evidence concerns the gene CTLA4 and neoplasm.